Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.76 USD
Change Today -0.01 / -0.56%
Volume 1.9M
UNIS On Other Exchanges
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

unilife corp (UNIS) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/27/15 - $4.90
52 Week Low
07/22/15 - $1.67
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for UNILIFE CORP (UNIS)

Related News

No related news articles were found.

unilife corp (UNIS) Related Businessweek News

View More BusinessWeek News

unilife corp (UNIS) Details

Unilife Corporation designs, manufactures, and supplies injectable drug delivery systems in the United States and internationally. The company offers Unifill, a pre-filled syringe with integrated, automatic, and user-controlled retraction; Unifill Finesse, an integrated, automatic, and user-controlled retraction with standard plunger seal and plunger rod; Unifill Select, which allows an end-user to select and attach a needle at the time of injection; Unifill Nexus that is equipped with an integrated luer adapter to provide connectivity with needleless luer access devices; and Unifill Allure, which combines universal luer connectivity with automatic, user-controlled needle retraction. It also provides ReadyToGo platform of wearable injectors designed for pre-filled, disposable devices that can be worn by a patient over periods during the subcutaneous injection of therapies; LISA smart reusable auto-injector; and RITA disposable auto-injector, an ergonomic single-use product. In addition, the company offers drug reconstitution delivery systems, including AutoMix Presto, an automatic reconstitution for single-step mixing and injection; EZMix Genesis, a ventless one-step reconstitution and automatic user-controlled retraction; EZMix Engage, a one step reconstitution to attach and retract a needle; and EZMix Prodigy, a single-barrel reconstitution system with a pre-fillable syringe. Further, it provides ocular delivery systems comprising Ocu-ject for the delivery of microliter sized doses to the eye; Ocu-mix, a dual-chamber syringe platform to reconstitute or mix, and deliver various therapies into the eye with a single injection; and Depot-ject, which places a drug depot into the eye. Additionally, the company offers Micro-ject to optimize the delivery of therapies with microliter doses that are unsuited to conventional device technologies. It serves pharmaceutical and biotechnology companies. The company was founded in 2002 and is headquartered in York, Pennsylvania.

209 Employees
Last Reported Date: 09/15/14
Founded in 2002

unilife corp (UNIS) Top Compensated Officers

Chairman, Chief Executive Officer, Member of ...
Total Annual Compensation: $630.0K
President and Chief Operating Officer
Total Annual Compensation: $726.0K
Chief Compliance Officer and Vice President o...
Total Annual Compensation: $308.0K
Senior Vice President and Controller
Total Annual Compensation: $308.0K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $52.3K
Compensation as of Fiscal Year 2014.

unilife corp (UNIS) Key Developments

Unilife Corporation - Special Call

To update shareholders on its business activities and introduce the Imperium™ platform of instant insulin patch pumps

Unilife Corporation Announces Introduction of Imperium™ Platform of Instant Patch Pumps for Insulin

Unilife Corporation announced the introduction of the Imperium™ platform of instant patch pumps for insulin. Imperium is a prefilled, disposable, multi-day wearable insulin pump that does not require filling or assembly by the patient. Because it is prefilled and pre-assembled like an insulin pen, only three intuitive steps are required to commence continuous subcutaneous insulin infusion, with on-demand bolus delivery available to the user via the simple push of a button. Imperium can include wireless connectivity systems, such as Bluetooth LE, to integrate with smartphone apps for patient reminders and status updates. With data connectivity available, healthcare providers could also have access to real-time or historic data to tailor the insulin therapy for each patient to achieve and maintain glycemic control. Imperium is designed for supply to a select insulin partner or partners ready for filling and packaging using standard pharmaceutical processes, materials and equipment. Insulin partners can then sell the prefilled, fully-assembled device through existing commercial channels, with no sales, marketing, commercial development, reimbursement, and clinical support costs to Unilife. As a prefilled, high-precision device with a delivery resolution of 0.5µL, Imperium is suitable for use with high concentration insulins up to U-500.

Unilife Corporation Mulls Acquisitions

Unilife Corporation (ASX:UNS) is seeking acquisitions. Unilife Corporation has signed an equity purchase agreement for up to AUD 45 million with Lincoln Park Capital Fund, LLC which provides the company with AUD 5 million in initial net proceeds and the option to generate, at its sole control and discretion, up to AUD 40 million in additional net proceeds over 24 months. Unilife Corporation said, “The Company intends to use the net proceeds received from the financing with Lincoln Park Capital Fund, LLC and the at-the-market facility for investments in its plant, equipment, systems and personnel to further develop its manufacturing and operational capabilities to satisfy current and future customer orders and general corporate purposes, including working capital, acquisitions and other business opportunities.”


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UNIS:US $1.76 USD -0.01

UNIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Becton Dickinson and Co $152.15 USD +0.15
West Pharmaceutical Services Inc $59.87 USD +0.09
Ypsomed Holding AG SFr.107.20 CHF +0.20
View Industry Companies

Industry Analysis


Industry Average

Valuation UNIS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNILIFE CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at